Patent US4575495A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4575495A Expired / Lapsed US ⏱️ 0.0 years remaining

Synthetic antigenic peptide derived from Hepatitis B surface antigen

Assignee: New York Blood Center
•
Filing: 1984-07-17
•
Granted: 1986-03-11
•
Expires: 2004-07-17
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract There is disclosed a new synthetic peptide which evokes an immunological response. The synthetic peptide, moreover, interacts with antibodies to Hepatitis B surface antigen (HBsAG). Thus, the synthetic peptide is useful as an immunizing agent in a vaccine as an active component thereof where it serves to produce antibodies in vivo which are protective against Hepatitis B virus. The synthetic peptide of the invention comprises the following sequence of amino acids: Arg Trp Met Met Leu Arg Arg(I) and preferably has the following sequence: Gly Tyr Arg Trp Met Met Leu Arg Arg Phe Gly (II).

Inventors

  • 👤 John Vnek
  • 👤 Alfred M. Prince
  • 👤 Hafeez Ikram

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-04 22:13
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/005; A; A61; A61K; A61K39/00; C12; C12N; C12N2730/00; C12N2730/00011; C12N2730/10011; C12N2730/10111; C12N2730/10122; Y; Y10; Y10S; Y10S930/00; Y10S930/01; Y10S930/22; Y10S930/223

Claims Analysis

Total Claims: 5
Claim 1
Independent Claim 28 words
A synthetic peptide consisting essentially of the following sequence of amino acids Arg Trp Met Met Leu Arg Arg (I) wherein said peptide is disposed on a carrier.
Claim 2
Dependent Claim 28 words
A synthetic peptide consisting essentially of the following sequence of amino acids Arg Trp Met Met Leu Arg Arg (I) wherein said peptide is disposed on a carrier.
Claim 3
Dependent Claim 15 words
A synthetic peptide according to claim 1, wherein said carrier is a physiologically acceptable carrier.
Claim 4
Dependent Claim 13 words
A synthetic peptide according to claim 2, wherein said carrier comprises tetanus toxoid.
Claim 5
Dependent Claim 13 words
A synthetic peptide according to claim 1, wherein said carrier comprises polyethylene glycol.

References Cited (Backward Citations)

US4428941A Cited
US4493796A Cited
EP0056249A2 Cited
US4499080A Cited
US4499081A Cited
US4496521A Cited
US4493795A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1989-03-10 1989-09-09 1990-03-11 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1993-03-10 1993-09-09 1994-03-11 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1997-03-10 1997-09-09 1998-03-11 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag